Home / News / CMS advises on the sale of radio-onkologie amsler...

CMS advises on the sale of radio-onkologie amsler ag

Zurich, 16 April 2021 | BAMCAM Holding AG sold all shares in radio-onkologie amsler ag to stock exchange listed Atrys Health Group.

Founded in 2003, radio-onkologie amsler ag today is one of the main providers of radiotherapy in the Basel area and operates two medical centers in Allschwil and Liestal.

Atrys Health (www.atryshealth.com) is a Spanish biomedical company dedicated to providing diagnostic services and medical treatments primarily for oncology patients. Its activity mainly comprise diagnostic laboratory, telemedicine and radiotherapy.

The acquisition is part of Atrys Health’s long-term strategy to create a pan-European network of oncology clinics for high precision radiotherapy treatments and scale R&D for hypofractionated radiotherapy. Being the first acquisition of Atrys Health in Switzerland, it shall allow Atrys Health to enter a new market and add to its existing radiotherapy operations in Portugal and Spain.

A team from CMS Switzerland led by partner Stephan Werlen advised BAMCAM Holding AG on all legal matters of the transaction.

 CMS Switzerland

  • Dr Stephan Werlen, Partner, Corporate / M&A
  • Alexandra Stocker, Associate, Corporate / M&A
  • Dr Simone Brauchbar Birkhäuser, Counsel, IP / IT

Related people

Portrait ofStephan Werlen
Dr Stephan Werlen, LL.M.
Partner
Zurich
Portrait ofSimone Brauchbar Birkhäuser, LL.M.
Dr Simone Brauchbar Birkhäuser, LL.M.
Partner
Zurich
Alexandra Stocker